These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2899820)

  • 1. Prevention of post-transfusion infectious complications.
    Hönlinger M; Reibnegger G; Schönitzer D; Wachter H
    Lancet; 1988 Aug; 2(8607):405-6. PubMed ID: 2899820
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of post-transfusion hepatitis.
    Conrad ME
    Lancet; 1988 Jul; 2(8604):217. PubMed ID: 2456435
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-transfusion hepatitis.
    Crawford RJ; Mitchell R
    Lancet; 1981 Aug; 2(8241):312. PubMed ID: 6114358
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of post-transfusion non-A, non-B hepatitis].
    Habibi B; Smilovici W
    Rev Fr Transfus Immunohematol; 1988 Oct; 31(3):537-86. PubMed ID: 3144032
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B immune globulin to prevent non-A, non-B post-transfusion hepatitis.
    Sugg U; Schneider W; Hoffmeister HE; Huth C; Stephan W; Lissner R; Haase W
    Lancet; 1985 Feb; 1(8425):405-6. PubMed ID: 2857461
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfusion-associated non-A, non-B hepatitis. Where do we go from here?
    Seeff LB; Dienstag JL
    Gastroenterology; 1988 Aug; 95(2):530-3. PubMed ID: 3134271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
    Daito K; Suou T; Kawasaki H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
    [No Abstract]   [Full Text] [Related]  

  • 8. Surrogate testing for non-A, non-B hepatitis.
    Anderson CC; Contreras M; Barbara JA; Mijovic V
    Lancet; 1987 Apr; 1(8538):912. PubMed ID: 2882303
    [No Abstract]   [Full Text] [Related]  

  • 9. Posttransfusion cirrhosis, non-A, non-B hepatitis, and the acquired immunodeficiency syndrome.
    Schmidt PJ
    Ann Intern Med; 1987 Oct; 107(4):597-8. PubMed ID: 3115163
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening of blood donations for hepatitis C virus antibody.
    Kimber RJ
    Med J Aust; 1990 Jun; 152(11):613. PubMed ID: 2112223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does the determination of serum neopterin secure blood transfusion?].
    Wilmer A; Tilg H; Vogel W
    Dtsch Med Wochenschr; 1992 May; 117(19):765. PubMed ID: 1576945
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-A, non-B hepatitis: new findings and prospects for prevention.
    Tabor E; Gerety RJ
    Transfusion; 1979; 19(6):669-74. PubMed ID: 118555
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential diagnosis between non-A, non-B hepatitis and fatty liver by measurement of urinary neopterin.
    Reibnegger G; Judmaier G; Wachter H
    Lancet; 1988 Mar; 1(8584):529. PubMed ID: 2893936
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood transfusion and hepatitis: what does it take to prevent new infections?
    Abdella Y; Riedner G; Hajjeh R; Sibinga CTS
    East Mediterr Health J; 2018 Jul; 24(6):595-597. PubMed ID: 30079955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selection of donors in the prevention of post-transfusion viral hepatitis].
    Massaro AL
    Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematologic care of the surgical patient.
    Berkman SA
    Hosp Pract (Off Ed); 1986 Feb; 21(2):124DD, 124GG-124HH, 124JJ passim. PubMed ID: 3081528
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential of urinary neopterin excretion in differentiating chronic non-A, non-B hepatitis from fatty liver.
    Prior C; Fuchs D; Hausen A; Judmaier G; Reibnegger G; Werner ER; Vogel W; Wachter H
    Lancet; 1987 Nov; 2(8570):1235-7. PubMed ID: 2890855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
    Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
    Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of post-transfusional hepatitis].
    Hernández JM
    Sangre (Barc); 1988 Jun; 33(3):242. PubMed ID: 3140399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?].
    Brandt KH
    Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.